209 related articles for article (PubMed ID: 25300552)
1. Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.
Garbuzenko OB; Winkler J; Tomassone MS; Minko T
Langmuir; 2014 Nov; 30(43):12941-9. PubMed ID: 25300552
[TBL] [Abstract][Full Text] [Related]
2. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
3. Development of l-Amino-Acid-Based Hydroxyl Functionalized Biodegradable Amphiphilic Polyesters and Their Drug Delivery Capabilities to Cancer Cells.
Saxena S; Jayakannan M
Biomacromolecules; 2020 Jan; 21(1):171-187. PubMed ID: 31592651
[TBL] [Abstract][Full Text] [Related]
4. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
5. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.
Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S
Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838
[TBL] [Abstract][Full Text] [Related]
6. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
7. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
8. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells.
Liu Q; Zhang J; Sun W; Xie QR; Xia W; Gu H
Int J Nanomedicine; 2012; 7():999-1013. PubMed ID: 22403484
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
10. PEG-coumarin nanoaggregates as π-π stacking derived small molecule lipophile containing self-assemblies for anti-tumour drug delivery.
Behl G; Kumar P; Sikka M; Fitzhenry L; Chhikara A
J Biomater Sci Polym Ed; 2018 Mar; 29(4):360-375. PubMed ID: 29271302
[TBL] [Abstract][Full Text] [Related]
11. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
12. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
13. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
[TBL] [Abstract][Full Text] [Related]
14. Novel dipeptide nanoparticles for effective curcumin delivery.
Alam S; Panda JJ; Chauhan VS
Int J Nanomedicine; 2012; 7():4207-22. PubMed ID: 22915849
[TBL] [Abstract][Full Text] [Related]
15. Dual Functional Nanocarrier for Cellular Imaging and Drug Delivery in Cancer Cells Based on π-Conjugated Core and Biodegradable Polymer Arms.
Kulkarni B; Surnar B; Jayakannan M
Biomacromolecules; 2016 Mar; 17(3):1004-16. PubMed ID: 26842888
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
[TBL] [Abstract][Full Text] [Related]
17. Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers.
Kim B; Seo B; Park S; Lee C; Kim JO; Oh KT; Lee ES; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2017 Oct; 158():157-166. PubMed ID: 28688365
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
19. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
20. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
